These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22424977)

  • 1. Development of hypoxia-sensitive Gd3+-based MRI contrast agents.
    Iwaki S; Hanaoka K; Piao W; Komatsu T; Ueno T; Terai T; Nagano T
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2798-802. PubMed ID: 22424977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
    Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum albumin targeted, pH-dependent magnetic resonance relaxation agents.
    Moriggi L; Yaseen MA; Helm L; Caravan P
    Chemistry; 2012 Mar; 18(12):3675-86. PubMed ID: 22328098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and relaxivity studies of a tetranuclear gadolinium(III) complex of DO3A as a contrast-enhancing agent for MRI.
    Jebasingh B; Alexander V
    Inorg Chem; 2005 Dec; 44(25):9434-43. PubMed ID: 16323930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
    Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
    Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of r₁ and r₂ relaxivity of gadolinium-based contrast agents on the T₁-weighted MR signal at increasing magnetic field strengths.
    Hagberg GE; Scheffler K
    Contrast Media Mol Imaging; 2013; 8(6):456-65. PubMed ID: 24375901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting the Proton Exchange as an Additional Route to Enhance the Relaxivity of Paramagnetic MRI Contrast Agents.
    Aime S; Baroni S; Delli Castelli D; Brücher E; Fábián I; Serra SC; Fringuello Mingo A; Napolitano R; Lattuada L; Tedoldi F; Baranyai Z
    Inorg Chem; 2018 May; 57(9):5567-5574. PubMed ID: 29687717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
    Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthogonal synthesis of a heterodimeric ligand for the development of the Gd(III)-Ga(III) ditopic complex as a potential pH-sensitive MRI/PET probe.
    Vologdin N; Rolla GA; Botta M; Tei L
    Org Biomol Chem; 2013 Feb; 11(10):1683-90. PubMed ID: 23360969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling.
    Chen SH; Kuo YT; Singh G; Cheng TL; Su YZ; Wang TP; Chiu YY; Lai JJ; Chang CC; Jaw TS; Tzou SC; Liu GC; Wang YM
    Inorg Chem; 2012 Nov; 51(22):12426-35. PubMed ID: 23116118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd3+ complexes: an attempt towards calcium-sensitive MRI contrast agents.
    Mishra A; Fousková P; Angelovski G; Balogh E; Mishra AK; Logothetis NK; Tóth E
    Inorg Chem; 2008 Feb; 47(4):1370-81. PubMed ID: 18166011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gadolinium(III)-water hydrogen distance in MRI contrast agents.
    Caravan P; Astashkin AV; Raitsimring AM
    Inorg Chem; 2003 Jun; 42(13):3972-4. PubMed ID: 12817950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates.
    Fulton DA; O'Halloran M; Parker D; Senanayake K; Botta M; Aime S
    Chem Commun (Camb); 2005 Jan; (4):474-6. PubMed ID: 15654374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
    Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG
    Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrocyclic Gd3+ chelates attached to a silsesquioxane core as potential magnetic resonance imaging contrast agents: synthesis, physicochemical characterization, and stability studies.
    Henig J; Tóth E; Engelmann J; Gottschalk S; Mayer HA
    Inorg Chem; 2010 Jul; 49(13):6124-38. PubMed ID: 20527901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
    Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
    Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
    Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic studies of Gd3+-based MRI contrast agents for Zn2+ detection: towards rational design.
    Bonnet CS; Caillé F; Pallier A; Morfin JF; Petoud S; Suzenet F; Tóth É
    Chemistry; 2014 Aug; 20(35):10959-69. PubMed ID: 25116889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.